IL2RG and Immunodeficiency: To accomplish this goal, greater immunodeficiency is required, which is provided by the generation of NOD/SCID mice with IL2rg mutations (NSG) that are able to engraft almost all types of cancer due to their enhanced immunodeficiency (109).